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Abstract
Uptake of contraceptives is generally low in low-income settings. For women with HIV, 
contraception is a reliable and affordable method of minimizing vertical transmission. We 
investigated the factors that affect contraceptive use among Kenyan women using data collected 
during the Kenya Demographic & Health Survey (KDHS) of 2014. Data on contraceptive use were 
extracted from the 2014 KDHS database. Records of 31,079 Kenyan women of reproductive age 
(15–49 years) were analyzed. Frequencies were calculated; cross-tabulations and bivariate and 
multivariate analyses were conducted. Twelve thousand thirty-two women (39%) reported using a 
contraceptive method. Region, religion, education, number of living children, marital status, and 
prior testing for HIV were significantly associated with contraceptive use among women (P<.001). 
Social, economic, and demographic factors predict contraceptive use among Kenyan women and 
should be addressed in order to increase contraceptive uptake.
INTRODUCTION
Sub-Saharan Africa had the highest fertility rate globally, at 4 or more children born per 
woman, in the years 2010–2015.[1] The proportion of women of reproductive age who use 
contraceptives is 22%, which is lower than half the rate in South Asia (53%) and a third the 
rate in East Asia (77%).[2] The population in sub-Saharan Africa continues to grow at a rate 
of 2.3% because of declining mortality coupled with high fertility.[2] While contraceptive 
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use is increasing by 0.7% per year across the African continent, many women still have 
difficulties accessing contraceptives.[3]
HIV-infected women in sub-Saharan Africa are at great risk for unwanted pregnancy.[4] Use 
of contraception is important in preventing unwanted pregnancy and is a reliable and 
affordable method of preventing vertical transmission of HIV from mother to child.[5] In 
India, on average, 10.3% of women living with HIV reported that their current pregnancy 
was unwanted.[6] Among pregnant HIV-positive women participating in a Nigerian study,[7] 
37.2% confirmed not wanting their pregnancy. Similarly, in a recent study in eastern and 
southern Africa,[8] approximately 24% of all deaths among pregnant and postpartum 
women were associated with HIV. More than 40% of pregnancies in Kenya are either 
unwanted or mistimed.[9] Through mother-to-child transmission of HIV, Kenya is 
accountable for 4% of all new pediatric HIV infections globally and 7% of all child deaths.
[10]
Several decades after the introduction of modern contraceptive methods, Kenya’s population 
continues to grow and is projected to exceed 60 million by 2025.[11] Like other developing 
countries, Kenya experienced a decline in fertility, from 4.9 births per woman in 2003 to 3.9 
births per woman in 2014.[12] However, the decline in fertility has stagnated due to factors 
such as reduced availability of modern contraceptive methods, diversion of resources to 
HIV/AIDS prevention and treatment, and inadequate support for family planning programs.
[11] According to the Kenya Demographic & Health Survey (KDHS) 2008–2009, 
contraceptive-use prevalence was 46%, a result that did not meet the 2010 benchmark of 
62% set by the Kenya National Population Policy for Sustainable Development in the year 
2000. KDHS 2008–2009 further reported that the use of modern contraceptives was low 
(37.6%) in urban Kenya.[13] The rapid population growth driven by high fertility poses 
serious challenges for social and economic development.
In Kenya, there is limited research on contraceptive use among women. We sought to 
determine the prevalence and factors associated with use of contraceptives among Kenyan 
women of reproductive age to inform the improvement of family planning services.
METHODS
Study design
This study was a secondary analysis of data from the KDHS 2014, a national survey 
conducted by the Kenya National Bureau of Statistics (KNBS) in partnership with other 
government and donor agencies.[12] KNBS conducts surveys every 5 years to monitor 
population and health in Kenya. The KDHS provides estimates of selected demographic and 
health indicators at the national level. It also provides data on general health, family 
planning, and HIV/AIDS programs needed by the government to effectively plan and 
implement future interventions.
Sampling
The methods used to collect data for the KDHS have been described elsewhere.[12] Briefly, 
all 47 counties in Kenya were stratified into rural and urban cluster. Using the Fifth National 
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Sample Survey and Evaluation Program (NASSEP V) sampling frame, the KDHS had a 2-
stage design. The first stage identified 1612 clusters: 617 urban and 995 rural. In the second 
stage of sampling, 25 households per cluster were selected using household listings, for a 
total of 40,300 households. Within these households, 31,079 Kenyan women of reproductive 
age (15–49 years) were surveyed.
Measurements
Two questionnaires—1 for each household and 1 for a selected woman in each household—
were used to collect contraceptive-use data in the KDHS. The household questionnaire was 
used to record all members of a household and to identify a woman therein to interview. If a 
household had more than 1 woman of reproductive age, the woman to interview was chosen 
by consensus among the women in the household. The chosen woman was asked whether 
she was using any method of contraception. If her response was yes, she was asked to name 
it, selecting from modern methods (ie, injectable, implant, oral pill, male condom, and other 
[eg, diaphragm, female sterilization, male sterilization, female condom, foam/jelly]) and 
natural methods (eg, periodic abstinence, withdrawal(pre-ejaculation), abstinence, 
lactational amenorrhea).
Independent variables included age, highest education attained, marital status, number of 
children and number still living, employment status, self-ranking in the wealth index (ie, 
poor, middle class, or rich), whether she had ever tested for HIV, and type of residence (ie, 
rural or urban).
Data analysis
STATA version 12 (StataCorp, College Station, Texas, USA) was used for data analysis. 
Frequency distributions and percentages were calculated to describe the characteristics of 
the target population. Prevalence of contraceptive use was estimated as the number of 
women who reported using contraceptives divided by the total number of women 
interviewed, expressed as a percentage. Cross-tabulations were used to determine the 
prevalence of contraceptive use by independent variable, each expressed as a percentage. 
Log-binomial regression models were used for estimating unadjusted and adjusted 
prevalence ratios and corresponding 95% confidence intervals. Log-binomial models were 
preferable to logistic regression models because they can give more precise estimates when 
prevalence is high. Variables associated with contraceptive use in the bivariate analysis 
(likelihood ratio test [LRT] P<.05) were included in the multivariate log-binomial model. 
Factors were retained in the log-binomial model if their inclusion did not make the model 
significantly worse at an LRT P value of less than .05.
Ethical considerations
We made a request to MEASURE DHS (Monitoring and Evaluation to Assess and Use 
Results of Demographic and Health Surveys program) for authorization to use the KDHS 
2014 data set. Permission was granted, and a link to access the data set was provided.
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RESULTS
There were 31,079 women who participated in the KDHS 2014, and they were split fairly 
evenly among 3 age categories (37.0% were aged 15–24 years; 33.4% were 25–34 years; 
and 29.6% were 35–49 years) (Table 1). Most (50.2%) had primary education, and 13.5% 
had no education. The majority (61.3%) were married. Most of the women (62.6%) resided 
in rural areas, and most (64.6%) were Protestant Christians. Wealth-index status was split 
mostly between poor (42.6%) and rich (38.3%), with significantly fewer in the middle-class 
category (19.1%). A large majority of women (83.1%) had been tested for HIV.
Prevalence of contraceptive use
The prevalence of contraceptive use among all women in the study was 38.7%. Use of 
contraceptives was more common among women aged 25–34 years (51.2%), women who 
had tertiary education (47.6%), and women who were married (51.6%). Contraceptive use 
varied by region, from 2.8% in the North Eastern region to 51.3% in the Central region. 
Muslim women had the lowest rate of contraceptive use (13.1%), compared with women 
who had other religions. Contraceptive use was more common among those who were 
working (51.0%) vs not working (23.2%). It decreased as the number of living children 
increased—with the exception of women who had no children; they had the lowest rate of 
contraceptive use (7.3%). It was also far more common among women who had tested for 
HIV (44.9%) than among those who had not (8.6%).
Determinants of contraceptive use
Factors independently associated with contraceptive use in a multivariate analysis included 
education, marital status, region, religion, number of living children, and having tested for 
HIV. Women who had secondary or tertiary education were more likely to use contraceptives 
(adjusted prevalence ratio [aPR] = 1.64 and 1.77, respectively), followed by women who had 
primary education (adjusted prevalence ratio [aPR] =1.60), compared with women who had 
no education (Table 1). Widowed and separated women were 0.48 times and 0.62 times, 
respectively, as likely as single women to use contraceptives, and women in the North 
Eastern region of Kenya were 0.17 times as likely as their coastal counterparts. Muslim 
women (0.41, 95% CI, 0.37–0.45) and women who had no religion (0.44, 95% CI, 0.37–
0.54) were less likely to use contraceptives in comparison with Catholics. Having at least 1 
child was positively associated with contraceptive use (1–3 children [aPR 2.30], 4–6 
children [2.46], 7–9 children [2.42], and 10–12 children [1.18]), compared with having no 
children. Women who responded yes to ever having tested for HIV were 1.52 times as likely 
to use contraceptives as women who had not tested.
Types of contraceptive methods
Table 2 describes preferred methods among the 12,032 women in the KDHS 2014 who used 
contraception. Among all of these women, injectable was the most preferred method at 
45.8%, followed by implant (16.4%), oral pill (12.0%), other modern method (10.8%), 
natural method (8.5%), and male condom (6.5%). The most dramatic difference in 
contraception choice was based on the number of living children a woman had; 53.9% of 
women who had no living children preferred male condoms, whereas only 4.6% of women 
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who had 1–3 living children (and lower for those who had more) preferred male condoms. 
There were also differences by HIV testing status: more women who had ever tested for HIV 
preferred injectables (46.1%) and implants (16.7%), compared with women who had never 
tested (37.9% and 7.4%, respectively).
DISCUSSION
Contraceptive uptake in our study was 39%, which was lower than the target of 62% set by 
the Kenya National Population Policy for Sustainable Development in 2000.[11] Regional 
disparities in usage were evident in our study, between the North Eastern region and all other 
regions in Kenya. The North Eastern part of Kenya is populated predominantly by Muslims, 
who were also the least likely to use contraceptives in this study. This is comparable with an 
analysis by the National Family Health Surveys in India on barriers to modern contraceptive 
practices among Asian women, which showed that Muslim women had greater opposition to 
using contraceptives than women who had other religions.[14] The authors explained that 
Muslim wives usually have more children than non-Muslim wives, are more likely to desire 
additional children, and hence are less likely to use contraception.
We found that most study participants (83%) had ever tested for HIV, and we found a 
positive association between having tested for HIV and using contraception. Wekesa and 
Coast found that two-thirds of people living with HIV/AIDS in Nairobi wanted to stop 
having children.[5] This indicates a possibility that women will use multiple technologies to 
prevent both HIV and pregnancy. A woman who has been tested for HIV and uses 
contraception may be open to the use of other technologies, such as pre-exposure 
prophylaxis, for HIV prevention. Additionally, this can be an encouragement for women to 
participate in HIV clinical vaccine trials in which HIV counseling and testing as well as 
pregnancy prevention are required.
Our study could not determine reasons for low contraceptive uptake, as this question was not 
asked in the KDHS. As observed by Kabagenyi et al (2014), lack of men’s involvement in 
family planning has largely contributed to low uptake of contraceptives.[15] Because men 
often lead the decision-making process in family matters, their noninvolvement in family 
planning can affect a woman’s decision regarding use of contraceptives.[15] Having 
misconceptions about contraception is another reason why women avoid it.[16] 
Contraceptive use is often thought to be for married women only,[16] and some women 
avoid contraceptives because They fear physical or medical complications.[17] Some people 
are also concerned about a possible increase in the risk for HIV transmission among women 
who use injectable depot medroxyprogesterone acetate (DMPA).[18] These factors may 
contribute greatly to the low uptake of contraceptives among women of reproductive age in 
Kenya. Studies that explore deterrents to contraceptive use among Kenyan women could 
help provide answers.
This study had limitations. It was conducted at 1 time point and relied on participant recall. 
However, the effect may be minimal given the large sample size. There could have been 
confounding or effect modification among the different factors, as shown by the prevalence 
ratios in the bivariate and multivariate analyses. However, we did not hypothesize any 
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primary exposure while estimating changes in the prevalence ratios. Our analysis sought 
only to explore factors associated with contraceptive use. Finally, the large sample size may 
have resulted in small differences becoming statistically significant without being clinically 
meaningful.
CONCLUSION
This study sought to measure contraceptive use and the factors that influence it among 
women in Kenya. Low uptake of contraceptives can have negative repercussions on maternal 
and infant health, including mistimed or unwanted pregnancy, as well as adolescent 
pregnancy that can lead to unsafe abortion or early marriage. It can also result in population 
growth, posing serious socioeconomic and developmental challenges. Studies are needed to 
understand the reasons for low uptake of contraception among Kenyan women in order to 
develop appropriate education and counseling messages. Such messages may need to be 
region- and population-specific and integrated into HIV testing and counseling services.
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Table 1.
Sociodemographic characteristics, contraceptive use, and log-binomial multivariate regression model among 
Kenyan women, KDHSa 2014 (N=31,079)
Characteristic Category Total
n (%)
Contraceptive use
n (%)
Multivariate analysisc
(aPRb) (95% CI)
Overall – 31079 (100) 12032 (38.7)
Age group (years) 15–24 11483 (37.0) 2569 (22.4) Ref
25–34 10391 (33.4) 5320 (51.2) 1.01 (1.01–1.01)
35–49 9205 (29.6) 4143 (45.0) 0.94 (0.94–0.94)
Education level None 4183 (13.5) 469 (11.2) Ref
Primary 15613 (50.2) 6876 (44.0) 1.60 (1.60–1.60)
Secondary 8595 (27.7) 3408 (39.7) 1.64 (1.64–1.64)
Tertiary 2688 (8.6) 1279 (47.6) 1.77 (1.77–1.77)
Marital status Single 8575 (27.6) 1071 (12.5) Ref
Married 19036 (61.3) 9829 (51.6) 1.27 (1.27–1.27)
Widowed 1191 (3.8) 304 (25.5) 0.48 (0.42–0.55)
Separated 2277 (7.3) 828 (36.4) 0.62 (0.57–0.67)
Residence type Urban 11614 (37.4) 4839 (41.7) Ref
Rural 19465 (62.6) 7193 (37.0) 0.96 (0.96–0.96)
Region Coast 3902 (12.6) 1240 (31.8) Ref
N. Eastern 1664 (5.4) 46 (2.8) 0.17 (0.11–0.26)
Eastern 5247 (16.9) 2307 (44.0) 1.02 (1.02–1.02)
Central 3114 (10.0) 1599 (51.3) 1.01 (1.01–1.01)
Rift Valley 9059 (29.1) 3333 (36.8) 0.94 (0.94–0.94)
Western 2840 (9.1) 1226 (43.2) 1.00 (1.00–1.00)
Nyanza 4254 (13.7) 1829 (43.0) 0.96 (0.96–0.96)
Nairobi 999 (3.2) 452 (45.2) 1.02 (1.02–1.02)
Religion Catholic 6229 (20.0) 2518 (40.4) Ref
Protestant 20072 (64.6) 8817 (43.9) 1.00 (1.00–1.00)
Muslim 4161 (13.4) 544 (13.1) 0.41 (0.37–0.45)
No religion 579 (2.0) 134 (23.1) 0.44 (0.37–0.54)
Employment status Not working 6273 (42.6) 1453 (23.2) Ref
Working 8451 (57.4) 4307 (51.0) 1.15 (1.15–1.15)
Wealth-index status Poor 13232 (42.6) 4015 (30.3) Ref
Mid. class 5946 (19.1) 2729 (45.9) 1.11 (1.11–1.11)
Rich 11901 (38.3) 5288 (44.4) 1.10 (1.10–1.10)
Number of living children 0 7981 (25.7) 579 (7.3) Ref
1–3 13946 (44.9) 7282 (52.2) 2.30 (2.30–2.30)
4–6 7092 (22.8) 3476 (49.0) 2.46 (2.46–2.46)
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Characteristic Category Total
n (%)
Contraceptive use
n (%)
Multivariate analysisc
(aPRb) (95% CI)
7–9 1857 (6.0) 642 (34.6) 2.42 (2.42–2.42)
10–12 200 (0.6) 52 (26.0) 1.18 (0.84–1.66)
13–15 3 (0.0) 1 (33.3)
–
d
Ever tested for HIV No 5241 (16.9) 449 (8.6) Ref
Yes 25682 (83.1) 11529 (44.9) 1.52 (1.52–1.52)
a
Kenya Demographic & Health Survey.
bAdjusted prevalence ratio.
c
Because of very small standard errors, the prevalence ratios were similar to their confidence intervals in multivariate analysis.
d
Insufficient data to calculate estimate.
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Table 2.
Contraceptive preference among Kenyan women who use contraception, KDHSa 2014 (N=12,032)
Characteristic Category Injectable
n (%)
Implant
n (%)
Oral pill
n (%)
Male condom
n (%)
Other modern
n (%)
Natural method
n (%)
Overall N=12,032 5516 (45.8) 1969 (16.4) 1439 (12.0) 786 (6.5) 1295 (10.8) 1027 (8.5)
Age group 15–24 1342 (52.2) 406 (15.8) 219 (8.5) 329 (12.8) 52 (2.0) 221 (8.6)
25–34 2682 (50.4) 1011 (19.0) 642 (12.1) 257 (4.8) 387 (7.3) 341 (6.4)
35–49 1492 (36.0) 552 (13.3) 578 (14.0) 200 (4.8) 845 (20.4) 476 (11.5)
Education level None 223 (47.6) 82 (17.5) 39 (8.3) 21 (4.5) 39 (8.3) 65 (13.9)
Primary 3491 (50.8) 1132 (16.5) 738 (10.7) 293 (4.3) 738 (10.7) 484 (7.0)
Secondary 1469 (43.1) 533 (15.6) 472 (13.9) 285 (8.4) 325 (9.5) 324 (9.5)
Tertiary 333 (26.0) 222 (17.4) 190 (14.9) 187 (14.6) 182 (14.2) 165 (12.9)
Marital status Single 365 (34.1) 116 (10.8) 83 (7.6) 352 (32.9) 28 (2.6) 127 (11.9)
Married 4636 (47.2) 1638 (16.7) 1254 (12.8) 344 (3.5) 1106 (11.3) 851 (8.7)
Widowed 114 (37.5) 48 (15.8) 32 (10.5) 30 (9.9) 63 (20.7) 17 (5.6)
Separated 401 (48.4) 167 (20.2) 70 (8.5) 60 (7.3) 87 (10.5) 43 (5.2)
Residence type Urban 1987 (41.1) 865 (17.9) 709 (14.7) 381 (7.9) 510 (10.5) 387 (8.0)
Rural 3529 (49.1) 1104 (15.4) 730 (10.2) 405 (5.6) 774 (10.8) 651 (9.1)
Region Coast 555 (44.8) 216 (17.4) 153 (12.3) 66 (5.3) 99 (8.0) 151 (12.1)
N. Eastern 24 (52.1) 7 (15.2) 7 (15.2) 2 (4.4) 2 (4.4) 4 (8.7)
Eastern 1166 (50.5) 276 (12.0) 289 (12.5) 132 (5.7) 238 (10.3) 206 (8.9)
Central 485 (30.3) 241 (15.1) 393 (24.6) 89 (5.6) 278 (17.4) 113 (7.1)
Rift Valley 1648 (49.4) 450 (13.5) 313 (9.4) 223 (6.7) 296 (8.9) 403 (12.1)
Western 546 (44.5) 320 (26.1) 95 (7.7) 76 (6.2) 145 (11.8) 44 (3.6)
Nyanza 938 (51.3) 373 (20.4) 108 (5.9) 148 (8.1) 178 (9.7) 84 (4.6)
Nairobi 154 (34.1) 86 (19.0) 81 (17.9) 50 (11.1) 48 (10.6) 33 (7.3)
Religion Catholic 1119 (44.4) 404 (16.0) 311 (12.4) 181 (7.2) 265 (10.5) 238 (9.5)
Protestant 4081 (46.3) 1441 (16.3) 1043 (11.8) 568 (6.4) 968 (11.0) 716 (8.1)
Muslim 237 (43.6) 94 (17.3) 80 (14.7) 28 (5.2) 35 (6.4) 70 (2.9)
No religion 70 (52.2) 27 (20.1) 3 (2.2) 9 (6.7) 13 (9.7) 12 (9.0)
Employment status Not working 666 (45.8) 250 (17.2) 158 (10.9) 127 (8.7) 107 (7.4) 145 (10.0)
Working 1899 (44.1) 713 (16.6) 523 (12.1) 284 (6.6) 508 (11.8) 380 (8.8)
Wealth-index status Poor 2175 (54.2) 662 (16.5) 320 (8.0) 192 (4.8) 333 (8.3) 333 (8.3)
Middle class 1341 (49.1) 442 (16.2) 281 (10.3) 159 (5.8) 295 (10.8) 211 (7.7)
Rich 2000 (37.8) 865 (16.4) 838 (15.9) 435 (8.2) 656 (12.4) 494 (9.3)
Number of living 
children
0 76 (13.1) 11 (1.9) 62 (10.7) 312 (53.9) 6 (1.0) 112 (19.3)
1–3 3583 (49.2) 1248 (17.1) 990 (13.6) 334 (4.6) 600 (8.2) 527 (7.2)
4–6 1590 (45.7) 603 (17.4) 335 (9.6) 120 (3.5) 536 (15.4) 292 (8.4)
7–9 252 (39.3) 102 (15.9) 46 (7.2) 19 (3.0) 127 (19.8) 96 (15.0)
10–12 15 (28.9) 5 (9.6) 5(9.6) 1 (1.9) 15 (28.9) 11 (21.1)
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Characteristic Category Injectable
n (%)
Implant
n (%)
Oral pill
n (%)
Male condom
n (%)
Other modern
n (%)
Natural method
n (%)
13–15 0 (0.0) 0 (0.0) 1 (100) 0 (0.0) 0 (0.0) 0 (0.0)
Ever tested for HIV No 170 (37.9) 33 (7.4) 62 (13.8) 61 (13.6) 65 (14.5) 58 (12.9)
Yes 5317 (46.1) 1929 (16.7) 1372 (11.9) 724 (6.3) 1210 (10.5) 977 (8.5)
a
Kenya Demographic & Health Survey.
AIDS Behav. Author manuscript; available in PMC 2019 July 01.
